| These are great questions, and thank you for asking them! 1. Yes. The claim based on the misreading of the 2019 paper is that SARS-CoV-2 is actually a lab-created combination of another coronavirus and the human immunodeficiency virus, or HIV. If that were true, the genome of SARS-CoV-2 would incorporate large parts of the HIV genome verbatim. It does not; comparing these genomes for identical or nearly identical subsequences via BLAST, by far the tool most widely used for this purpose, shows no such similarity. 2. Viral recombination occurs when multiple related strains of a given virus infect the same cell at the same time. That can be done in vitro, but I haven't seen any papers from WIV describing such experiments. Notably, the frequently cited 2019 paper describes a totally different kind of experiment, which could not under any circumstances have produced a virus with the genome which SARS-CoV-2 has been observed to have. 3. For that to happen would require two different strains of the same virus to independently develop the same mutation allowing them to cross over and infect humans, and to simultaneously infect the same worker in the lab, and to then recombine in such a way as to produce SARS-CoV-2. That is not impossible, but it is about as likely to occur as it is for every atom in your body to simultaneously transmute into gold. |
I find the wet market theory full of such improbabilities too. How is ncov19 relatively close to two known viruses, 1) the sars like bat virus it was 96% similar to, and 2) the pangolin virus with which it has resembling receptor proteins. Seems a lot of coincidence for these two to combine, both of which can jump to humans, and 300 meters from a leading Coronavirus research lab.
I know I'm just repeating the conspiracy theory, but just explaining my position. The virus was found initially at the wet market, and there is no proof of its origin being there. Plus it seems perfectly feasible for it come out of the lab and not be a deliberately engineered virus, atleast not one using the 2019 paper's chimera virus techniques.